Reducing inequalities is also one of the main aims of Public Health England. So I'm really pleased that today we're publishing the PHE Screening inequalities strategy.
Professor Anne Mackie
Professor Anne Mackie is the Director of Programmes for the UK National Screening Committee.
Anne has worked in Public Health for nearly 20 years across London and the South East. Previous roles have included medical director of the National Specialist Commissioning Advisory Group, Director of Public Health in Kent and Director of Public Health in South West London. Latterly Anne was Director of Public Health for London SHA before taking on her current post in August 2007. She lives in London with her partner and their daughter.
Professor Anne Mackie reflects on the hard work and achievements of everyone involved in screening during 2017.
Today we’ve published – after several years of hard work by many talented people – a large set of resources that can help providers ensure high quality local screening services.
Dr Anne Mackie, Director of PHE Screening, explains how inequalities affect screening and what actions we are taking to understand and address these differences.
The annual call is your opportunity to make a proposal for a new topic to be considered by the UK NSC as part of its regular review process.
I’m delighted to report that following the sterling work of our child vision group, we are now consulting on all the draft resources they have produced.
Some of us in Public Health England (PHE), myself included, have worked in screening a long time.
In the short video below, Dr Anne Mackie, Director of Screening for Public Health England, reflects on screening's achievements during 2016.
Group B Streptococcus (GBS) is an important cause of illness in babies, children and elderly adults. It remains the commonest infection that causes serious illness in newborn babies.
A new test will be added to the fetal anomaly screening pathway following an announcement by the Department of Health.